TSMRF(TSMRF)
TSMRF
No analyst ratings available
No analyst price targets available for TSMRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $217.26B | $231.02B | $241.26B | $251.54B | $276.56B |
| Low | $213.51B | $226.89B | $237.02B | $247.12B | $271.70B |
| High | $221.48B | $235.17B | $245.76B | $256.23B | $281.71B |
| EBITDA Avg | $53.24B | $57.22B | $60.79B | $60.14B | $75.36B |
| Low | $52.41B | $56.36B | $59.91B | $59.32B | $74.25B |
| High | $54.12B | $58.13B | $61.73B | $61.00B | $76.54B |
| EBIT Avg | $37.04B | $38.21B | $39.27B | $36.34B | $49.08B |
| Low | $36.21B | $37.35B | $38.39B | $35.52B | $47.97B |
| High | $37.92B | $39.12B | $40.21B | $37.20B | $50.25B |
| Net Income Avg | $25.87B | $26.71B | $27.46B | $25.37B | $34.43B |
| Low | $25.28B | $26.10B | $26.83B | $24.79B | $33.64B |
| High | $26.50B | $27.35B | $28.12B | $25.99B | $35.27B |
| EPS Avg | $346.24 | $357.41 | $367.47 | $339.58 | $460.78 |
| Low | $338.32 | $349.24 | $359.07 | $331.81 | $450.25 |
| High | $354.63 | $366.07 | $376.37 | $347.80 | $471.95 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $54.54B | $59.99B | $52.06B |
| Low | $53.13B | $58.91B | $50.93B |
| High | $55.94B | $61.07B | $53.19B |
| EBITDA Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EBIT Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 2 / — | 2 / — | 1 / — |